Venture-Gain - doing business as VG Bioinformatics - commercializes pattern-recognizing technology in areas that include Cardiology - Heart Rhythm Monitoring, Intensive Care Unit - Patient Monitoring, Clinical Patient Data, Telehealth - Home/Remote Patient Monitoring, Sleep Disorders and Genomics/Pharmaceuticals. As healthcare transforms from a reactive care delivery model to a preventative delivery model, new clinical processes and business strategies are required. By monitoring patients to prevent an acute admission, healthcare organizations can provide a higher quality of life, significantly reduce the cost of healthcare and improve communication between patient and caregiver. Remotely obtaining continuous ambulatory and in-patient vital sign data will ensure real-time information is delivered on the state of the patientÂ’s health. The new challenge is turning that critical data into clinically relevant and actionable information that will drive a whole new paradigm of proactive healthcare. Our solutions include proven predictive analytics, expertise in applying advanced technologies to highly complex systems and deep knowledge of the healthcare environment to help ensure the earliest possible detection of a patientÂ’s deteriorating condition. These solutions help clinicians identify patients that require proactive intervention, resulting in less hospital admissions and allowing patients to live a more vibrant and independent life. VG-Bio is committed to leading this new paradigm in transforming proactive healthcare today.
